251 related articles for article (PubMed ID: 9022761)
1. Application of magnetization transfer imaging for intracranial lesions of tuberous sclerosis.
Jeong MG; Chung TS; Coe CJ; Jeon TJ; Kim DI; Joo AY
J Comput Assist Tomogr; 1997; 21(1):8-14. PubMed ID: 9022761
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of MR sequences to detect structural brain lesions in tuberous sclerosis.
Pinto Gama HP; da Rocha AJ; Braga FT; da Silva CJ; Maia AC; de Campos Meirelles RG; Mendonça do Rego JI; Lederman HM
Pediatr Radiol; 2006 Feb; 36(2):119-25. PubMed ID: 16283285
[TBL] [Abstract][Full Text] [Related]
3. Improved contrast of enhancing brain lesions on postgadolinium, T1-weighted spin-echo images with use of magnetization transfer.
Finelli DA; Hurst GC; Gullapali RP; Bellon EM
Radiology; 1994 Feb; 190(2):553-9. PubMed ID: 8284415
[TBL] [Abstract][Full Text] [Related]
4. Magnetization transfer in the investigation of patients with tuberous sclerosis.
Girard N; Zimmerman RA; Schnur RE; Haselgrove J; Christensen K
Neuroradiology; 1997 Jul; 39(7):523-8. PubMed ID: 9258933
[TBL] [Abstract][Full Text] [Related]
5. Value of magnetization transfer contrast in intracranial enhancing and nonenhancing lesions with paramagnetic contrast agents.
Hamatake S; Korogi Y; Sakamoto Y; Ikushima I; Hirai T; Takahashi M
Radiat Med; 1997; 15(5):295-303. PubMed ID: 9445151
[TBL] [Abstract][Full Text] [Related]
6. MR imaging of tuberous sclerosis: pathogenesis of this phakomatosis, use of gadopentetate dimeglumine, and literature review.
Braffman BH; Bilaniuk LT; Naidich TP; Altman NR; Post MJ; Quencer RM; Zimmerman RA; Brody BA
Radiology; 1992 Apr; 183(1):227-38. PubMed ID: 1549677
[TBL] [Abstract][Full Text] [Related]
7. Analysis of magnetization transfer effects on T1-weighted spin-echo scans using a simple tissue phantom simulating gadolinium-enhanced brain lesions.
Finelli DA; Hurst GC; Frank HA; Gullapali RP; Apicella A
J Magn Reson Imaging; 1997; 7(4):731-8. PubMed ID: 9243395
[TBL] [Abstract][Full Text] [Related]
8. Macroscopic tumor volume of malignant glioma determined by contrast-enhanced magnetic resonance imaging with and without magnetization transfer contrast.
Hawighorst H; Schreiber W; Knopp MV; Essig M; Engenhart-Cabilic R; Brix G; van Kaick G
Magn Reson Imaging; 1996; 14(10):1119-26. PubMed ID: 9065901
[TBL] [Abstract][Full Text] [Related]
9. Pre- and postcontrast MR studies in tuberous sclerosis.
Wippold FJ; Baber WW; Gado M; Tobben PJ; Bartnicke BJ
J Comput Assist Tomogr; 1992; 16(1):69-72. PubMed ID: 1729309
[TBL] [Abstract][Full Text] [Related]
10. Gadolinium-DTPA enhanced MR imaging in tuberous sclerosis.
Martin N; Debussche C; De Broucker T; Mompoint D; Marsault C; Nahum H
Neuroradiology; 1990; 31(6):492-7. PubMed ID: 2352631
[TBL] [Abstract][Full Text] [Related]
11. Magnetization transfer effects on T1-weighted three-dimensional gradient-echo MR images of a phantom simulating enhancing brain lesions.
Finelli DA
AJNR Am J Neuroradiol; 1997 Jan; 18(1):147-59. PubMed ID: 9010534
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging of musculoskeletal lesions: comparison of three fat-saturation pulse sequences.
Pui MH; Goh PS; Choo HF; Fok EC
Australas Radiol; 1997 May; 41(2):99-102. PubMed ID: 9153802
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and pitfalls of contrast-enhanced, T1-weighted magnetization transfer images of the brain.
Higano S; Shrier DA; Numaguchi Y; Shibata DK; Kwok E
Acad Radiol; 2000 Mar; 7(3):156-64. PubMed ID: 10730810
[TBL] [Abstract][Full Text] [Related]
14. The role of fat-suppression technique and gadopentetate dimeglumine in magnetic resonance imaging evaluation of intraocular tumors and simulating lesions.
De Potter P; Flanders AE; Shields JA; Shields CL; Gonzales CF; Rao VM
Arch Ophthalmol; 1994 Mar; 112(3):340-8. PubMed ID: 8129659
[TBL] [Abstract][Full Text] [Related]
15. Magnetization transfer effects in MR-detected multiple sclerosis lesions: comparison with gadolinium-enhanced spin-echo images and nonenhanced T1-weighted images.
Hiehle JF; Grossman RI; Ramer KN; Gonzalez-Scarano F; Cohen JA
AJNR Am J Neuroradiol; 1995 Jan; 16(1):69-77. PubMed ID: 7900604
[TBL] [Abstract][Full Text] [Related]
16. Brain MR post-gadolinium contrast in multiple sclerosis: the role of magnetization transfer and image subtraction in detecting more enhancing lesions.
Gavra MM; Voumvourakis C; Gouliamos AD; Sfagos C; Vlahos LJ
Neuroradiology; 2004 Mar; 46(3):205-10. PubMed ID: 14985887
[TBL] [Abstract][Full Text] [Related]
17. Central nervous system tumor, infection, and infarction: detection with gadolinium-enhanced magnetization transfer MR imaging.
Mehta RC; Pike GB; Haros SP; Enzmann DR
Radiology; 1995 Apr; 195(1):41-6. PubMed ID: 7892492
[TBL] [Abstract][Full Text] [Related]
18. Half-dose gadolinium-enhanced MR imaging with magnetization transfer technique in brain tumors: comparison with conventional contrast-enhanced MR imaging.
Han D; Chang KH; Han MH; Cho JY; Han SW; Kim HD; Seong SO
AJR Am J Roentgenol; 1998 Jan; 170(1):189-93. PubMed ID: 9423630
[TBL] [Abstract][Full Text] [Related]
19. [Subependymal giant cell astrocytoma in patients with tuberous sclerosis: magnetic resonance imaging findings in ten cases].
Takata K; Gasparetto EL; Leite Cda C; Lucato LT; Reed UC; Matushita H; Aguiar PH; Rosemberg S
Arq Neuropsiquiatr; 2007 Jun; 65(2A):313-6. PubMed ID: 17607434
[TBL] [Abstract][Full Text] [Related]
20. Cranial tissues: appearance at gadolinium-enhanced and nonenhanced MR imaging with magnetization transfer contrast.
Elster AD; King JC; Mathews VP; Hamilton CA
Radiology; 1994 Feb; 190(2):541-6. PubMed ID: 8284413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
